In Malta, the National Infectious Disease Surveillance Unit in the Department of Health receives notifications of positive cases from virology departments and prisons. There were no reports of newly diagnosed cases of human immunodeficiency virus (HIV) infection linked to injecting drug use in 2017.
|Data from 2016/17 (HIV) and from 2017 (HCV).|
|National||44.54||0.0 - 1.2|
Prevalence estimates of HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV) come from diagnostic tests among people who inject drugs seeking treatment at the outpatient treatment unit run by Sedqa, the Maltese government’s executive agency in the drugs field. In 2016, two clients out of 170 tested positive for HIV. In 2017, 53 out of 119 tested positive for hepatitis C antibodies and one out of 83 tested positive for hepatitis B antibodies.